Po‐Chen Chu

968 total citations
37 papers, 628 citations indexed

About

Po‐Chen Chu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Po‐Chen Chu has authored 37 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Po‐Chen Chu's work include Cancer-related Molecular Pathways (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and DNA Repair Mechanisms (4 papers). Po‐Chen Chu is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and DNA Repair Mechanisms (4 papers). Po‐Chen Chu collaborates with scholars based in Taiwan, United States and China. Po‐Chen Chu's co-authors include Jing‐Ru Weng, Li-Yuan Bai, Chang-Fang Chiu, Shih-Jiuan Chiu, Samuel K. Kulp, Ching‐Shih Chen, Hsiao-Ching Chuang, Mau-Sun Chang, Ching‐Shiun Chen and Yen‐Ta Lu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Po‐Chen Chu

36 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Chen Chu Taiwan 15 411 114 100 56 53 37 628
Glenn S. Van Aller United States 10 627 1.5× 83 0.7× 116 1.2× 37 0.7× 85 1.6× 14 882
Peter R. McDonald United States 17 456 1.1× 74 0.6× 166 1.7× 73 1.3× 43 0.8× 44 772
Huanchun Zhang United States 13 470 1.1× 138 1.2× 65 0.7× 117 2.1× 23 0.4× 20 672
Junmei Hou China 5 302 0.7× 95 0.8× 109 1.1× 22 0.4× 35 0.7× 5 502
Guadalupe Domínguez-Gómez Mexico 16 373 0.9× 200 1.8× 135 1.4× 53 0.9× 19 0.4× 38 678
Alina Malyutina Finland 9 549 1.3× 78 0.7× 138 1.4× 40 0.7× 23 0.4× 12 836
Malte Paulsen Germany 14 511 1.2× 88 0.8× 102 1.0× 25 0.4× 58 1.1× 21 850
Beata Olejnicka Sweden 12 325 0.8× 133 1.2× 75 0.8× 21 0.4× 58 1.1× 27 622
Run‐Lei Du China 19 643 1.6× 157 1.4× 121 1.2× 35 0.6× 133 2.5× 33 855

Countries citing papers authored by Po‐Chen Chu

Since Specialization
Citations

This map shows the geographic impact of Po‐Chen Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Chen Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Chen Chu more than expected).

Fields of papers citing papers by Po‐Chen Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Chen Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Chen Chu. The network helps show where Po‐Chen Chu may publish in the future.

Co-authorship network of co-authors of Po‐Chen Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Chen Chu. A scholar is included among the top collaborators of Po‐Chen Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Chen Chu. Po‐Chen Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Li-Yuan, et al.. (2025). A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells. International Journal of Medical Sciences. 22(5). 1081–1091. 2 indexed citations
2.
Huang, Hui‐Chi, Jui‐Ming Liu, Guanlin Chen, et al.. (2024). Inhibition of Autophagy Aggravates Arachis hypogaea L. Skin Extracts-Induced Apoptosis in Cancer Cells. International Journal of Molecular Sciences. 25(2). 1345–1345. 8 indexed citations
3.
Weng, Jing‐Ru, et al.. (2023). A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells. Chemico-Biological Interactions. 380. 110538–110538. 10 indexed citations
4.
Lin, Hsiang‐Wen, et al.. (2023). A non-invasive mouse model that recapitulates disuse-induced muscle atrophy in immobilized patients. Scientific Reports. 13(1). 22201–22201. 3 indexed citations
5.
Wu, Yu‐Chieh, et al.. (2022). Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors. Bioorganic Chemistry. 121. 105681–105681. 4 indexed citations
6.
Chang, Chih‐Shiang, Vathan Kumar, Der‐Yen Lee, et al.. (2021). Development of Novel Rhodacyanine-Based Heat Shock Protein 70 Inhibitors. Current Medicinal Chemistry. 28(26). 5431–5446. 7 indexed citations
7.
Chu, Po‐Chen, et al.. (2021). Novel HIF-1α Inhibitor CDMP-TQZ for Cancer Therapy. Future Medicinal Chemistry. 13(12). 1057–1072. 6 indexed citations
8.
Chiu, Chang-Fang, Jing‐Ru Weng, Chia-Yung Wu, et al.. (2020). OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels. Biochemical Pharmacology. 174. 113811–113811. 9 indexed citations
10.
Chu, Po‐Chen, Peng-Chan Lin, Kuen‐Tyng Lin, et al.. (2018). Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Oncogene. 37(25). 3440–3455. 46 indexed citations
11.
Bai, Li-Yuan, Chang-Fang Chiu, Shih-Jiuan Chiu, Po‐Chen Chu, & Jing‐Ru Weng. (2017). FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism. Scientific Reports. 7(1). 5600–5600. 37 indexed citations
12.
Bai, Li-Yuan, et al.. (2016). A triterpenoid from wild bitter gourd inhibits breast cancer cells. Scientific Reports. 6(1). 22419–22419. 49 indexed citations
13.
Berman-Booty, Lisa D., Po‐Chen Chu, Jennifer M. Thomas‐Ahner, et al.. (2012). Suppression of Prostate Epithelial Proliferation and Intraprostatic Progrowth Signaling in Transgenic Mice by a New Energy Restriction-Mimetic Agent. Cancer Prevention Research. 6(3). 232–241. 8 indexed citations
14.
Chen, Chia‐Hsin, Po‐Chen Chu, Chi‐Chen Fan, et al.. (2012). Disruption of Murine mp29/Syf2/Ntc31 Gene Results in Embryonic Lethality with Aberrant Checkpoint Response. PLoS ONE. 7(3). e33538–e33538. 19 indexed citations
15.
Chu, Po‐Chen, Hsiao-Ching Chuang, Samuel K. Kulp, & Ching‐Shih Chen. (2012). The mRNA-stabilizing Factor HuR Protein Is Targeted by β-TrCP Protein for Degradation in Response to Glycolysis Inhibition. Journal of Biological Chemistry. 287(52). 43639–43650. 46 indexed citations
16.
Fan, Chi‐Chen, et al.. (2011). hPuf-A/KIAA0020 Modulates PARP-1 Cleavage upon Genotoxic Stress. Cancer Research. 71(3). 1126–1134. 20 indexed citations
17.
Huang, Po-Hsien, Po‐Chen Chu, Mei-Chuan Chen, et al.. (2011). Energy Restriction-mimetic Agents Induce Apoptosis in Prostate Cancer Cells in Part through Epigenetic Activation of KLF6 Tumor Suppressor Gene Expression. Journal of Biological Chemistry. 286(12). 9968–9976. 14 indexed citations
18.
Chu, Po‐Chen, et al.. (2011). Investigation of the Relationship between Endometrial MMP Activities and Sex Hormones in Mature Bitches. The Thai Journal of Veterinary Medicine. 41(3). 289–298. 3 indexed citations
19.
Chu, Po‐Chen, et al.. (2009). Involvement of p29 in DNA damage responses and Fanconi anemia pathway. Carcinogenesis. 30(10). 1710–1716. 17 indexed citations
20.
Chang, Mau-Sun, Yen‐Ta Lu, Yun-Ting Hsu, et al.. (2004). Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochemical and Biophysical Research Communications. 314(4). 931–936. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026